About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 12840 record(s)
Req # A-2020-000904
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-110246-856.Organization: Health Canada
July 2024
Req # A-2020-001068
Adverse Drug Reactions (ADRs). Report numbers: 000736573, 000736721, 000736796, 000737181, 000737217, 000737554, 000737618, 000737726, 000737830, 000738070, 000738082, 000908178, 000908829, 000909010, 000909051, 000909683, 000909688, 000909810,…Organization: Health Canada
July 2024
Req # A-2020-001116
Adverse Drug Reactions (ADRs). Report numbers: E2B_02140813, E2B_02143262, E2B_02143363, E2B_02145327, E2B_02145331, E2B_02145563, E2B_02145566, E2B_02149242, E2B_02152966, E2B_02152971, E2B_02153003, E2B_02153271, E2B_02156628, E2B_02156987,…Organization: Health Canada
July 2024
Req # A-2020-001216
Adverse Drug Reactions (ADRs). Report numbers: E2B_02503694, E2B_02503833, E2B_02504356, E2B_02504680, E2B_02505306, E2B_02505626, E2B_ 02505737, E2B_02506655, E2B_02506783, E2B_02506888, E2B_02507085, E2B_02507216, E2B_02507239, E2B_02507295,…Organization: Health Canada
July 2024
Req # A-2021-001090
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-107916-342.Organization: Health Canada
July 2024
Req # A-2021-001096
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-112868-238.Organization: Health Canada
July 2024
Req # A-2021-001530
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: 000935818, 000938303.Organization: Health Canada
July 2024
Req # A-2022-000323
Adverse Drug Reactions (ADRs) for Invanz. Report numbers: E2B_02980169, E2B_02688263, E2B_03106484, E2B_02727599, E2B_02897744, E2B_02802085, E2B_03260531, 000911379, 000737908, 000728027.Organization: Health Canada
July 2024
Req # A-2022-001201
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-011904-710, Meet and Greet with Chair of the Board of Directors, Coalition for Epidemic Preparedness Innovations.Organization: Health Canada
July 2024
Req # A-2022-001461
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-113702-970.Organization: Health Canada
July 2024